New Orleans, LA, United States of America

Sergey S Shevkoplyas

USPTO Granted Patents = 11 (Patent Applications = 2)

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 3.8

ph-index = 6

Forward Citations = 94(Granted Patents)

Location History:

Cambridge, MA (US) (2013)
Friendwood, TX (US) (2016)
Brighton, MA (US) (2009 - 2017)
Friendswood, TX (US) (2017 - 2020)
New Orleans, LA (US) (2013 - 2021)

Company Filing History:

The Administrators of the Tulane Educational Fund

Halcyon Biomedical, Incorporated

patents

5. 1 out of 27

New Health Sciences, Inc.

where one patent can have more than one assignee

Years Active: 2009-2021

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10908152 - Paper based diagnostic test (2021-02-02),

2. 10705098 - Capillary network devices and methods of use (2020-07-07),

3. 9977037 - Capillary network devices and methods of use (2018-05-22),

4. 9789235 - Separation and concentration of particles (2017-10-17),

5. 9551706 - Density-based methods for separation of materials, monitoring of solid supported reactions and measuring densities of small liquid volumes and solids (2017-01-24),

6. 9409265 - Three dimensional assembly of diamagnetic materials using magnetic levitation (2016-08-09),

7. 9383350 - Engineered cell growth on polymeric films and biotechnological application thereof (2016-07-05),

8. 8828226 - System for assessing the efficacy of stored red blood cells using microvascular networks (2014-09-09),

9. 8492150 - Engineered cell growth on polymeric films and biotechnological applications thereof (2013-07-23),

10. 8486833 - Fabrication of conductive pathways, microcircuits and microstructures in microfluidic networks (2013-07-16),

11. 7517453 - Microvascular network device (2009-04-14),

Title: Innovations of Sergey S. Shevkoplyas: A Pioneer in Diagnostic and Microvascular Technologies

Introduction

Sergey S. Shevkoplyas is a distinguished inventor based in New Orleans, LA, known for his significant contributions to the field of diagnostics and microvascular technology. With an impressive portfolio of 11 patents, Shevkoplyas has established himself as a leading figure in innovation, focusing on cost-effective and efficient solutions for medical applications.

Latest Patents

Among his latest inventions, the "Paper-Based Diagnostic Test" stands out. This invention relates to the development of simple, low-cost diagnostic devices that offer rapid results. Such innovations are critical in enhancing accessibility to medical testing.

Another notable patent is the "Capillary Network Devices and Methods of Use." This invention involves artificial microvascular network (AMVN) devices designed to simulate the capillary networks found in various human and animal circulatory systems. These devices are valuable for investigating the effects of differing storage conditions on red blood cells (RBCs), showcasing their potential in both research and therapeutic applications.

Career Highlights

Throughout his career, Sergey S. Shevkoplyas has contributed to prestigious institutions, including Harvard College and the Administrators of the Tulane Educational Fund. His work has not only advanced scientific understanding but also has practical implications in the fields of medicine and biology.

Collaborations

Shevkoplyas has collaborated with esteemed colleagues, including George M. Whitesides and Tatsuro Yoshida. These partnerships underscore the collaborative nature of scientific research and innovation, allowing for the cross-pollination of ideas and expertise.

Conclusion

In summary, Sergey S. Shevkoplyas exemplifies the spirit of innovation through his numerous patents and collaborations. His work continues to impact the fields of diagnostics and microvascular research significantly. As technology advances, the contributions of inventors like Shevkoplyas pave the way for future developments that promote health and well-being.

This text is generated by artificial intelligence and may not be accurate.